Company type | Private |
---|---|
NYSE: PKI (until 2023) | |
Industry | Medtech |
Founded | 1937 |
Headquarters | Shelton, Connecticut, U.S. (2023) |
Key people | Dirk Bontridder, President and Chief Executive Officer |
Products | Analytical instruments, lab technologies, diagnostic testings, laboratory services, informatics, cord blood banking (2021) |
Revenue | US$5.0 billion (2021[1]) |
Owner | New Mountain Capital |
Number of employees | More than 16,000 (2021) |
Website | www |
PerkinElmer, Inc., previously styled Perkin-Elmer, is an American global corporation that was founded in 1937 and originally focused on precision optics. Over the years it went into and out of several different businesses via acquisitions and divestitures; these included defense products, semiconductors, computer systems, and others. By the 21st century, PerkinElmer was focused in the business areas of diagnostics, life science research, food, environmental and industrial testing. Its capabilities include detection, imaging, informatics, and service. It produced analytical instruments, genetic testing and diagnostic tools, medical imaging components, software, instruments, and consumables for multiple end markets. PerkinElmer was part of the S&P 500 Index and operated in 190 countries.
Over its history, PerkinElmer has been split in two twice. In 1999, PerkinElmer merged with EG&G, with the ongoing Analytical Instruments Division of Perkin-Elmer keeping that name, while the life sciences division of the company became the separate PE Corporation. In 2022, a split of PerkinElmer resulted in one part, comprising applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but kept the PerkinElmer name. The other part, comprising life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc.[2]